Page last updated: 2024-12-08
bana 113
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 446323 |
| CHEMBL ID | 55440 |
| SCHEMBL ID | 141675 |
| MeSH ID | M0258451 |
Synonyms (20)
| Synonym |
|---|
| 4-acetylamino-3-guanidino-benzoic acid |
| 3-carbamimidamido-4-acetamidobenzoic acid |
| bdbm4707 |
| chembl55440 , |
| 4-acetamido-3-(diaminomethyleneamino)benzoic acid |
| 3-(2,2-diaminoimino)-4-methylcarboxamidobenzoate |
| benzoic acid, 4-(acetylamino)-3-[(diaminomethylene)amino]- |
| 4-acetamido-3-guanidino-benzoic acid |
| bana 113 |
| bana-113 |
| bcx-140 |
| 1INF |
| SCHEMBL141675 |
| 170447-93-5 |
| unii-v02kf5948m |
| benzoic acid, 4-(acetylamino)-3-((aminoiminomethyl)amino)- |
| v02kf5948m , |
| UDQJOWCVSMIZJP-UHFFFAOYSA-N |
| bdbm50478626 |
| Q27291359 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a mouse model of influenza, 5 did not protect the mice from weight loss due to the influenza virus when dosed intranasally." | ( Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. Babu, YS; Bantia, S; Chand, P; Chu, N; Cole, LB; Kotian, PL; Laver, WG; Montgomery, JA; Pathak, VP; Petty, SL; Shrout, DP; Walsh, DA; Walsh, GM, 1997) | 0.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (8)
Inhibition Measurements
| Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| Chain A, INFLUENZA VIRUS B/LEE/40 NEURAMINIDASE | Influenza B virus | IC50 (µMol) | 10.0000 | 10.0000 | 10.0000 | 10.0000 | AID977608 |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | IC50 (µMol) | 1,249,890.0000 | 0.0000 | 0.5035 | 10.0000 | AID381951; AID384920 |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | IC50 (µMol) | 10.0000 | 0.0005 | 0.9767 | 10.0000 | AID147337 |
| Neuraminidase | Influenza A virus (A/tern/Australia/G70C/1975(H11N9)) | IC50 (µMol) | 7.5000 | 2.5000 | 2.5000 | 2.5000 | AID1795674; AID1795675; AID1795763; AID1795764 |
| Neuraminidase | Influenza B virus (B/Lee/1940) | IC50 (µMol) | 10.0000 | 0.0010 | 0.4028 | 10.0000 | AID147339; AID1795763; AID1795764 |
| Neuraminidase | Influenza B virus (B/Lee/1940) | Ki | 0.0025 | 0.0001 | 0.0010 | 0.0025 | AID147478 |
| Neuraminidase | Influenza A virus (A/Singapore/1/1957(H2N2)) | IC50 (µMol) | 10.0000 | 0.0010 | 0.0050 | 0.0170 | AID1795763 |
| Sialidase-3 | Homo sapiens (human) | IC50 (µMol) | 2.5000 | 2.4000 | 5.9980 | 8.1700 | AID147479 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Biological Processes (7)
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| viral release from host cell | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| carbohydrate metabolic process | Sialidase-3 | Homo sapiens (human) |
| ganglioside catabolic process | Sialidase-3 | Homo sapiens (human) |
| oligosaccharide catabolic process | Sialidase-3 | Homo sapiens (human) |
| positive regulation of epidermal growth factor receptor signaling pathway | Sialidase-3 | Homo sapiens (human) |
| glycosphingolipid catabolic process | Sialidase-3 | Homo sapiens (human) |
| negative regulation of clathrin-dependent endocytosis | Sialidase-3 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
Molecular Functions (7)
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| exo-alpha-sialidase activity | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| peptidase activator activity | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| exo-alpha-sialidase activity | Sialidase-3 | Homo sapiens (human) |
| protein binding | Sialidase-3 | Homo sapiens (human) |
| alpha-sialidase activity | Sialidase-3 | Homo sapiens (human) |
| exo-alpha-(2->3)-sialidase activity | Sialidase-3 | Homo sapiens (human) |
| exo-alpha-(2->6)-sialidase activity | Sialidase-3 | Homo sapiens (human) |
| exo-alpha-(2->8)-sialidase activity | Sialidase-3 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
Ceullar Components (10)
| Process | via Protein(s) | Taxonomy |
|---|---|---|
| extracellular region | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| plasma membrane | Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) |
| lysosomal membrane | Sialidase-3 | Homo sapiens (human) |
| plasma membrane | Sialidase-3 | Homo sapiens (human) |
| caveola | Sialidase-3 | Homo sapiens (human) |
| external side of plasma membrane | Sialidase-3 | Homo sapiens (human) |
| early endosome membrane | Sialidase-3 | Homo sapiens (human) |
| recycling endosome membrane | Sialidase-3 | Homo sapiens (human) |
| membrane | Sialidase-3 | Homo sapiens (human) |
| lysosome | Sialidase-3 | Homo sapiens (human) |
| cytoplasm | Sialidase-3 | Homo sapiens (human) |
| [Information is prepared from geneontology information from the June-17-2024 release] | ||
Bioassays (19)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1795764 | Neuraminidase Inhibition Assay from Article 10.1016/s0960-894x(99)00318-2: \\Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping.\\ | 1999 | Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14 | Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping. |
| AID1795675 | Neuraminidase Inhibition Assay from Article 10.1016/j.bmc.2005.01.042: \\Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase.\\ | 2005 | Bioorganic & medicinal chemistry, Apr-01, Volume: 13, Issue:7 | Synthesis and inhibitory activity of benzoic acid and pyridine derivatives on influenza neuraminidase. |
| AID1795674 | Neuraminidase Inhibition Assay from Article 10.1021/jm970479e: \\Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.\\ | 1997 | Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25 | Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. |
| AID1795763 | Neuraminidase Inhibition Assay from Article 10.1016/s0968-0896(99)00197-2: \\Hydrophobic benzoic acids as inhibitors of influenza neuraminidase.\\ | 1999 | Bioorganic & medicinal chemistry, Nov, Volume: 7, Issue:11 | Hydrophobic benzoic acids as inhibitors of influenza neuraminidase. |
| AID203526 | The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by fetuin assay | 1995 | Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17 | Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. |
| AID147333 | Inhibitory activity against N9 neuraminidase subtype | 2001 | Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6 | Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. |
| AID293513 | Inhibition of Trypanosoma cruzi recombinant Trans-sialidase at 1 mM | 2007 | Bioorganic & medicinal chemistry, Mar-01, Volume: 15, Issue:5 | Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase. |
| AID147331 | Inhibitory activity against N2 neuraminidase subtype | 2001 | Journal of medicinal chemistry, Mar-15, Volume: 44, Issue:6 | Comparative binding energy (COMBINE) analysis of influenza neuraminidase-inhibitor complexes. |
| AID203525 | The compound was tested in vitro for the inhibitory concentration against influenza B/Mem/89 sialidase from whole virus by MUN assay | 1995 | Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17 | Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. |
| AID203520 | The compound was tested in vitro for the inhibitory concentration against influenza N2 sialidase from whole virus by fetuin assay | 1995 | Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17 | Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. |
| AID147479 | In vitro inhibitory activity against H1N9 strain of Influenza Neuraminidase (membrane) | 1997 | Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25 | Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. |
| AID384920 | Inhibition of influenza virus neuraminidase | 2008 | European journal of medicinal chemistry, Mar, Volume: 43, Issue:3 | QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network. |
| AID147337 | In vitro inhibitory effect on N9 Influenza A neuraminidase | 1999 | Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14 | Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping. |
| AID203519 | The compound was tested in vitro for the inhibitory concentration against influenza N2 sialidase from whole virus by MUN assay | 1995 | Journal of medicinal chemistry, Aug-18, Volume: 38, Issue:17 | Structure-based inhibitors of influenza virus sialidase. A benzoic acid lead with novel interaction. |
| AID147339 | In vitro inhibitory effect on B/Lee Influenza B neuraminidase | 1999 | Bioorganic & medicinal chemistry letters, Jul-19, Volume: 9, Issue:14 | Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping. |
| AID381951 | Inhibition of Influenza A virus neuraminidase | 2008 | Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7 | Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors. |
| AID147478 | In vitro inhibitory activity against B/Lee/40 Influenza B Neuraminidase. | 1999 | Journal of medicinal chemistry, Jul-01, Volume: 42, Issue:13 | Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent. |
| AID977608 | Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB | 1997 | Journal of molecular biology, Apr-04, Volume: 267, Issue:3 | Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. |
| AID1811 | Experimentally measured binding affinity data derived from PDB | 1997 | Journal of molecular biology, Apr-04, Volume: 267, Issue:3 | Guanidinobenzoic acid inhibitors of influenza virus neuraminidase. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (11)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 11.84
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.84) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 11 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||